150 related articles for article (PubMed ID: 9542794)
1. A case of treatment-refractory psychosis responsive to sertindole.
Geracioti TD; Parker S; Lowther NB; Wortman M; Richtand NM
Schizophr Res; 1998 Feb; 30(1):105-8. PubMed ID: 9542794
[TBL] [Abstract][Full Text] [Related]
2. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.
Azorin JM; Murteira S; Hansen K; Toumi M
BMC Psychiatry; 2008 Mar; 8():16. PubMed ID: 18366634
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
Pezawas L; Quiner S; Moertl D; Tauscher J; Barnas C; Küfferle B; Wolf R; Kasper S
Int Clin Psychopharmacol; 2000 Jul; 15(4):207-14. PubMed ID: 10954060
[TBL] [Abstract][Full Text] [Related]
5. The atypical antipsychotic sertindole: a case series.
Lee AM; Knoll JL; Suppes T
J Clin Psychiatry; 1997 Sep; 58(9):410-6; quiz 417-8. PubMed ID: 9378698
[TBL] [Abstract][Full Text] [Related]
6. Case histories illustrating the utility of sertindole in clinical practice.
Schuck P; van den Ameele H; Jaanson P; Ryckmans V; Hawley C
CNS Drugs; 2004; 18 Suppl 2():31-40; discussion 41-3. PubMed ID: 15461314
[TBL] [Abstract][Full Text] [Related]
7. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient.
Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I
Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.
van Kammen DP; McEvoy JP; Targum SD; Kardatzke D; Sebree TB
Psychopharmacology (Berl); 1996 Mar; 124(1-2):168-75. PubMed ID: 8935813
[TBL] [Abstract][Full Text] [Related]
9. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
10. Sertindole : a review of its use in schizophrenia.
Murdoch D; Keating GM
CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
[TBL] [Abstract][Full Text] [Related]
11. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Perquin L; Steinert T
CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
[TBL] [Abstract][Full Text] [Related]
12. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
14. Sertindole for the treatment of schizophrenia.
Azorin JM; Kaladjian A; Fakra E; Adida M
Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
16. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
17. Sertindole in schizophrenia: efficacy and safety issues.
Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
19. A naturalistic pilot study comparing haloperidol, clozapine, sertindole, and risperidone in partially responsive chronic schizophrenia or schizoaffective disorder.
Fogelson DL; Sternbach H; Payne D
J Clin Psychopharmacol; 1997 Dec; 17(6):492-4. PubMed ID: 9408817
[No Abstract] [Full Text] [Related]
20. Sertindole for schizophrenia.
Lewis R; Bagnall A; Leitner M
Cochrane Database Syst Rev; 2000; (2):CD001715. PubMed ID: 10796657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]